Payment overview · 2025
General Payments
$218.24
12 reported records · 5 companies
Healthcare provider profile · identity verified
Sabina Ali, MD
Allopathic & Osteopathic Physicians|Internal Medicine · RICHMOND, VA · NPI 1861474348
Verified facts
What the public records show
CMS Open Payments records show Sabina Ali, MD received $218.24 in general payments during 2025 across 12 reported records.
Abbott Laboratories accounted for 47.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Trelegy Ellipta by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 84 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $104.37 | 47.8% | 6 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $58.48 | 26.8% | 3 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $20.63 | 9.4% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $17.69 | 8.1% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $17.07 | 7.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $218.24 | 12 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $104.37 | 6 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $58.48 | 3 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $20.63 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $20.63 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $17.69 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $17.07 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $17.07 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
24 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
84 | 22 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 666 | 173 |
| Amlodipine Besylate | Amlodipine Besylate | 575 | 155 |
| Levothyroxine Sodium | Levothyroxine Sodium | 397 | 101 |
| Famotidine | Famotidine | 285 | 82 |
| Losartan Potassium | Losartan Potassium | 274 | 78 |
| Gabapentin | Gabapentin | 239 | 64 |
| Fluticasone Propionate | Fluticasone Propionate | 203 | 69 |
| Metformin Hcl Er | Metformin Hcl | 202 | 57 |
| Furosemide | Furosemide | 200 | 62 |
| Metoprolol Succinate | Metoprolol Succinate | 199 | 56 |
| Omeprazole | Omeprazole | 194 | 57 |
| Hydrochlorothiazide | Hydrochlorothiazide | 188 | 51 |
| Simvastatin | Simvastatin | 185 | 52 |
| Ozempic | Semaglutide | 172 | 27 |
| Sertraline Hcl | Sertraline Hcl | 165 | 41 |
| Pravastatin Sodium | Pravastatin Sodium | 161 | 42 |
| Lisinopril | Lisinopril | 151 | 36 |
| Potassium Chloride | Potassium Chloride | 149 | 45 |
| Metformin Hcl | Metformin Hcl | 147 | 40 |
| Valsartan | Valsartan | 147 | 38 |
| Allopurinol | Allopurinol | 140 | 32 |
| Carvedilol | Carvedilol | 139 | 33 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 135 | 46 |
| Pantoprazole Sodium | Pantoprazole Sodium | 132 | 42 |
| Glipizide | Glipizide | 129 | 33 |
| Ibandronate Sodium | Ibandronate Sodium | 129 | 47 |
| Diclofenac Sodium | Diclofenac Sodium | 126 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 124 | 35 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 119 | 48 |
| Meloxicam | Meloxicam | 117 | 35 |
| Mounjaro | Tirzepatide | 103 | 17 |
| Tamsulosin Hcl | Tamsulosin Hcl | 102 | 32 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 98 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 97 | 20 |
| Trazodone Hcl | Trazodone Hcl | 97 | 28 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 94 | 23 |
| Spironolactone | Spironolactone | 90 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 88 | 29 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 85 | 30 |
| Amitriptyline Hcl | Amitriptyline Hcl | 84 | 25 |
| Eliquis | Apixaban | 84 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 82 | 24 |
| Jardiance | Empagliflozin | 82 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 79 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 79 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 75 | 15 |
| Montelukast Sodium | Montelukast Sodium | 72 | 23 |
| Trulicity | Dulaglutide | 72 | 14 |
| Buspirone Hcl | Buspirone Hcl | 68 | 17 |
| Pregabalin | Pregabalin | 68 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 64 | suppressed |
| Atenolol | Atenolol | 61 | 14 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 61 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 61 | 17 |
| Ezetimibe | Ezetimibe | 60 | 14 |
| Alendronate Sodium | Alendronate Sodium | 56 | 17 |
| Donepezil Hcl | Donepezil Hcl | 56 | 16 |
| Farxiga | Dapagliflozin Propanediol | 56 | 20 |
| Prednisone | Prednisone | 56 | 36 |
| Linzess | Linaclotide | 53 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 52 | 11 |
| Mirtazapine | Mirtazapine | 51 | 14 |
| Tramadol Hcl | Tramadol Hcl | 50 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | 12 |
| Solifenacin Succinate | Solifenacin Succinate | 48 | 13 |
| Bumetanide | Bumetanide | 47 | 12 |
| Memantine Hcl | Memantine Hcl | 45 | 11 |
| Tradjenta | Linagliptin | 45 | 12 |
| Alprazolam | Alprazolam | 44 | 19 |
| Levetiracetam | Levetiracetam | 43 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 34 |
| Glipizide Er | Glipizide | 41 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 40 | 27 |
| Clonidine Hcl | Clonidine Hcl | 38 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 38 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 37 | 12 |
| Diltiazem 24hr Er | Diltiazem Hcl | 37 | suppressed |
| Nystatin | Nystatin | 35 | 18 |
| Lorazepam | Lorazepam | 34 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 34 | 11 |
| Hydrocortisone | Hydrocortisone | 33 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 32 | suppressed |
| Lidocaine | Lidocaine | 32 | 18 |
| Bupropion Xl | Bupropion Hcl | 31 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 31 | suppressed |
| Januvia | Sitagliptin Phosphate | 30 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Risperidone | Risperidone | 29 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 28 | suppressed |
| Irbesartan | Irbesartan | 28 | suppressed |
| Klor-Con M20 | Potassium Chloride | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 27 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 26 | suppressed |
| Celecoxib | Celecoxib | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 25 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 24 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 24 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | 12 |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Baclofen | Baclofen | 21 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 21 | suppressed |
| Neupro | Rotigotine | 21 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 21 | suppressed |
| Synthroid | Levothyroxine Sodium | 21 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 20 | suppressed |
| Clonazepam | Clonazepam | 19 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Xarelto | Rivaroxaban | 19 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 18 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Klor-Con M10 | Potassium Chloride | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Ramipril | Ramipril | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Zafirlukast | Zafirlukast | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Finasteride | Finasteride | 16 | suppressed |
| Lactulose | Lactulose | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Sucralfate | Sucralfate | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Latanoprost | Latanoprost | 15 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $218.24 · 12 records | Abbott Laboratories | AREXVY, Cologuard Collection Kit, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, NURTEC ODT, SHINGRIX, ZAVZPRET | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error